While mild to moderate reductions in ADAMTS-13 activity have been observed, possibly associated with markedly increased VWF levels, severe ADAMTS-13 deficiency appears to be rare in COVID-19 [25, 26]. This evidence concerns the gene VWF and COVID-19.